PCSK9 and its clinical importance with the new therapeutic targets against dyslipidemia
Carlos Eduardo dos Santos Ferreira, Francisco Antônio Helfenstein Fonseca, Cristóvão Luis Pitangueira Mangueira
Einstein (São Paulo)
doi:10.1590/s1679-45082012000400024 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.